Role of Vitamin D3 in stroke patients

The effect of Vitamin D3 on clinical outcome of stroke patients in ICU- a prospective randomised double blind study - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098728

Enrollment

Registered

2025-12-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G968- Other specified disorders of central nervous system

Interventions

Intervention1: Single dose of 200000 IU intramuscular vitamin D3 in stroke patients: Single dose 200000 IU intramuscular vitamin D3 in stroke patients with serum vitamin D levels less than30ng/dl- Con

Eligibility

Inclusion criteria

Inclusion criteria: Patients in the age group of 18-75 years Patients of both sex Patients admitting to ICU with cerebrovascular stroke both ischemic and haemorrhagic with NIHSS score 5-24 ,diagnosis confirmed with CT/MRI

Exclusion criteria

Exclusion criteria: patients with vitamin D more than 30ng/ml patients on vitamin D supplementation patients with traumatic brain injury

Design outcomes

Primary

Measure	Time frame
will be patient disability of any degree as assessed by the modified Rankin scale 90 days. The modified Rankin Scale (mRS) is a 6-grades scales where 0 means no disability and 6 means death Timepoint: will be patient disability of any degree as assessed by the modified Rankin scale 90 days. The modified Rankin Scale (mRS) is a 6-grades scales where 0 means no disability and 6 means death - the score and vitamin D assesed at day 1,2,3,4,5,6,7,14,28,90.	—

Measure

Time frame

will be patient disability of any degree as assessed by the modified Rankin scale 90 days. The modified Rankin Scale (mRS) is a 6-grades scales where 0 means no disability and 6 means death Timepoint: will be patient disability of any degree as assessed by the modified Rankin scale 90 days. The modified Rankin Scale (mRS) is a 6-grades scales where 0 means no disability and 6 means death - the score and vitamin D assesed at day 1,2,3,4,5,6,7,14,28,90.

—

Secondary

Measure	Time frame
length of ICU stay , number of days of mechanical ventilation (MV days) and mRS clinical outcome at 28 days or at time of discharge or death whichever occurs earlier.Timepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Akrity Singh

Indira Gandhi Institute of Medical Sciences

drakrity_s@yahoo.co.in9431664293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026